Abstract: A robot connector, including: a connector configured to connect to a mounting surface of a robot; a guiding insert that is compressible, wherein the guiding insert has an opening configured to receive a guide tube; a guide tube holder with an opening wherein the guide tube is attached to the connector and the opening is configured to receive the compressible guiding insert; and a locking mechanism configured to lock the guiding insert and the guide tube to the connector.

Abstract: A seal ring for a bearing assembly includes an inner sleeve having an inner surface that defines a hollow for receiving a shaft therethrough, and an outer labyrinth ring fixed to the inner sleeve and including an interior surface that faces the inner sleeve and an exterior surface opposite the interior surface. The exterior surface forms a plurality of crests and at least one trough.

Abstract: A forest fire retardant composition contains a retardant compound that includes a salt. The salt may include a potassium salt, a phosphate salt, a sulfate salt, a calcium salt, a magnesium salt, and/or a halide salt, and combinations thereof. The composition may be in the form of a liquid concentrate dispersion or a final diluted product. The liquid concentrate dispersion may contain multiple phases including a dispersed phase and a dispersion medium. The final diluted product is effective in suppressing, retarding, and controlling forest fires while exhibiting corrosion resistance and low toxicity.

Abstract: Adjustable-length surgical access devices are disclosed herein, which can advantageously allow an overall length of the access device to be quickly and easily changed by the user. The access devices herein can reduce or eliminate the need to maintain an inventory of many different length access devices. In some embodiments, the length of the access device can be adjusted while the access device is inserted into the patient. This can reduce or eliminate the need to swap in and out several different access devices before arriving at an optimal length access device. This can also reduce or eliminate the need to change the access device that is inserted into a patient as the depth at which a surgical step is performed changes over the course of a procedure. Rather, the length of the access device can be adjusted in situ and on-the-fly as needed or desired to accommodate different surgical depths.

Abstract: An access device for accessing an intervertebral disc having an outer shield comprising an access shield with a larger diameter (˜16-30 mm) that reaches from the skin down to the facet line, with an inner shield having a second smaller diameter (˜5-12 mm) extending past the access shield and reaches down to the disc level. This combines the benefits of the direct visual microsurgical/mini open approaches and the percutaneous, “ultra-MIS” techniques.

Abstract: Implementations described herein relate to methods, systems, and computer-readable media. In some implementations, a method to transmit application data over a network connection may include receiving application data, determining a permitted data rate, shaping the application data received from each application of the plurality of applications based on the permitted data rate for the application into respective shaped application data, adding the shaped application data associated with each application to a queue, assigning the datagrams included in the queue to a particular data stream of a plurality of data streams based on metadata associated with each datagram included in the application data, applying stream level flow control to each data stream of the plurality of data streams to identify a subset of datagrams from the each data stream in the queue, generating a packet for transmission over the connection, and transmitting the packet over the network connection.

Abstract: Provided herein are systems, devices, and methods for performing optical multianalyte detection in a sample, such as a human blood sample. The system processes sample in a single-use support pack that holds the blood sample and contains pipette tips, buffers, reagent preparation wells and a monolayer. Sample is transferred from the sample pack to a single-use disc consumable that contains microwells pre-filled with dried chemistries, plasma separation features, and a hematocrit channel. The instrument comprises a cell imager, an absorbance module comprising a spectrophotometer, a fluorescent laser scanning module, and a camera. The system uses only a small amount of blood from a single heparinized sample, to simultaneously provide results for a full panel of routine blood tests spanning electrochemistry, clinical chemistry, hematology, immunoassays and combinations thereof.

Abstract: An articulating driver having a ball-in-socket joint. The driver may include a driver tip having a spherical head, a retention cap having a domed surface to mate with the spherical head, an input shaft, a spring disposed in an end of the input shaft and in a recess of the retention cap opposite that of the domed surface, and a housing that receives the input shaft, the spring, the retention cap and the spherical head. The housing may have a tapered end to positionally retain the spherical head therein. In another aspect, the driver may include a driver tip coupled to the input shaft that includes an interface to engage a screw. A bushing may engage the driver tip at one end and receive the screw at the other end to retain the screw within the driver.

Abstract: Blocking antibodies against ?M?2 (CBP-?-?M?2), ?M (CBP-?-?M), ?3 (CBP-?-?3), and anti-TGF? as well as inhibitors of Talin2 reverse fibrosis in a mouse fibrosis model. Accordingly, aspects of the disclosure relate to inhibitors of Talin2 and inhibitors of the integrins ?M?2, ?M, and ?3. Aspects relate to a method for treating and/or reversing fibrosis in a subject comprising administering a composition comprising an inhibitor of Talin2 or a composition comprising a nucleic acid of the disclosure. Further aspects relate to a method for treating and/or reversing fibrosis in a subject comprising administering a composition comprising an antibody conjugate of the disclosure or a composition comprising an inhibitor or blocking agent of integrin ?3, ?M, ?M?2, or combinations thereof to the subject. Methods also include treating kidney fibrosis in a subject comprising administering a composition comprising an anti-TGF? antibody operatively linked to an ECM-affinity peptide.

Abstract: The invention provides a composition comprising water, a chelating agent, and a pH adjustor. The invention also provides a method for removing residue from a surface of a microelectronic device substrate comprising contacting the surface of the microelectronic device substrate with a composition comprising water, a chelating agent, and a pH adjustor.

Abstract: An access device for accessing an intervertebral disc having an outer shield comprising an access shield with a larger diameter (˜16-30 mm) that reaches from the skin down to the facet line, with an inner shield having a second smaller diameter (˜5-12 mm) extending past the access shield and reaches down to the disc level. This combines the benefits of the direct visual microsurgical/mini open approaches and the percutaneous, “ultra-MIS” techniques.

Abstract: A wrench for automotive service, and in particular for service involving oil filters. The wrench comprises a torque head, torque handle, and a bracing member. The bracing member engages with the torque head to position the wrench with respect to a target body, such as an oil filter. The torque handle engages with the torque head to transfer torque from the torque handle to the torque head. The torque head is configured to transfer torque to the target body via grip surface. Additional features may provide additional functionality.

Abstract: One example method for video conference acceleration includes connecting, by an accelerator device, to a local area network (“LAN”), the LAN in communication with a wide area network (“WAN”); transmitting, via the LAN and the WAN, registration information to a video conference provider, the registration information identifying network configuration information; receiving, from the video conference provider via the WAN and the LAN, an identifier corresponding to the accelerator device; after receiving the identifier, receiving, from a first client device, a request to access a meeting; determining whether the meeting is available at the accelerator device; and in response to determining that the meeting is available at the accelerator device, transmitting access information to the first client device.

Abstract: A forest fire retardant composition contains a retardant compound that includes a phosphate salt. The phosphate salt may include diammonium phosphate, diammonium orthophosphate, monoammonium phosphate, monoammonium orthophosphate, monosodium phosphate, disodium phosphate, disodium phosphate hydrate, sodium ammonium phosphate, sodium ammonium phosphate hydrate, sodium tripolyphosphate, trisodium phosphate, or dipotassium phosphate, and combinations thereof. The forest fire retardant composition may include an ammonium source. The composition may be in the form of a dry concentrate, a liquid concentrate, or a final diluted product. The final diluted product is effective in suppressing, retarding, and controlling forest fires while exhibiting corrosion resistance and low toxicity.

Abstract: Provided herein are systems, devices, and methods for performing optical multianalyte detection in a sample, such as a human blood sample. The system processes sample in a single-use support pack that holds the blood sample and contains pipette tips, buffers, reagent preparation wells and a monolayer. Sample is transferred from the sample pack to a single-use disc consumable that contains microwells pre-filled with dried chemistries, plasma separation features, and a hematocrit channel. The instrument comprises a cell imager, an absorbance module comprising a spectrophotometer, a fluorescent laser scanning module, and a camera. The system uses only a small amount of blood from a single heparinized sample, to simultaneously provide results for a full panel of routine blood tests spanning elecochemistry, clinical chemistry, hematology, immunoassays and combinations thereof.

Abstract: A forest fire retardant composition contains a retardant compound that includes a potassium salt. The potassium salt may include a potassium salt of an organic acid, a potassium salt of an inorganic acid, or mixtures thereof. The organic acid may include formic acid, acetic acid, propanoic acid, butanoic acid, lactic acid, oxalic acid, malic acid, gluconic acid, tartaric acid, uric acid, malic acid, or citric acid. The inorganic acid may include sulfuric acid, phosphoric acid, carbonic acid, or hydrochloric acid. The composition may be in the form of a dry concentrate, a liquid concentrate, or a final diluted product. The final diluted product is effective in suppressing, retarding, and controlling forest fires while exhibiting corrosion resistance and low toxicity.

Abstract: A system, method, apparatus and diagnostic test for Plasmodium vivax, to determine a likelihood of a specific timing of infection by P. vivax in a subject, and hence identify individuals with a high probability of being infected with otherwise undetectable liver-stage hypnozoites. The system, method, apparatus and diagnostic test relate to the identification of hypnozoites (“dormant” liver-stages), or at least of the likelihood of the subject being so infected. Optionally and preferably, the specific timing relates to recent infections, for example within the last 9 months.

Abstract: One example method for video conference acceleration includes connecting, by an accelerator device, to a local area network (“LAN”), the LAN in communication with a wide area network (“WAN”); transmitting, via the LAN and the WAN, registration information to a video conference provider, the registration information identifying network configuration information; receiving, from the video conference provider via the WAN and the LAN, an identifier corresponding to the accelerator device; after receiving the identifier, receiving, from a first client device, a request to access a meeting; determining whether the meeting is available at the accelerator device; and in response to determining that the meeting is available at the accelerator device, transmitting access information to the first client device.

Abstract: A forest fire retardant composition contains a retardant compound that includes a phosphate salt. The phosphate salt may include diammonium phosphate, diammonium orthophosphate, monoammonium phosphate, monoammonium orthophosphate, monosodium phosphate, disodium phosphate, disodium phosphate hydrate, sodium ammonium phosphate, sodium ammonium phosphate hydrate, sodium tripolyphosphate, trisodium phosphate, or dipotassium phosphate, and combinations thereof. The forest fire retardant composition may include an ammonium source. The composition may be in the form of a dry concentrate, a liquid concentrate, or a final diluted product. The final diluted product is effective in suppressing, retarding, and controlling forest fires while exhibiting corrosion resistance and low toxicity.

Abstract: A forest fire retardant composition contains a retardant compound that includes a phosphate salt. The phosphate salt may include diammonium phosphate, diammonium orthophosphate, monoammonium phosphate, monoammonium orthophosphate, monosodium phosphate, disodium phosphate, disodium phosphate hydrate, sodium ammonium phosphate, sodium ammonium phosphate hydrate, sodium tripolyphosphate, trisodium phosphate, or dipotassium phosphate, and combinations thereof. The forest fire retardant composition may include an ammonium source. The composition may be in the form of a dry concentrate, a liquid concentrate, or a final diluted product. The final diluted product is effective in suppressing, retarding, and controlling forest fires while exhibiting corrosion resistance and low toxicity.